FDA – Comments Submitted to FDA on Considerations for Pediatric Studies for Drugs and Biological Products

Comments Submitted to FDA on Considerations for Pediatric Studies for Drugs and Biological Products. (Docket Number: FDA-2013-D-1275-0001).

read the comments